Ketamin Abcur

Ketamine, the active ingredient in Ketamin Abcur, is a NMDA receptor antagonist presented as a sterile injectable solution for intramuscular and intravenous use. It is employed for induction of anesthesia, analgesia, and sedation in surgical and procedural settings.

GNH USA supplies Ketamin Abcur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketamine is an NMDA receptor antagonist used in anesthesia and pain management.

- Induction of anesthesia: provides rapid loss of consciousness for surgical procedures. - Analgesia: offers effective pain relief in acute and procedural settings. - Sedation: facilitates moderate sedation for diagnostic or therapeutic procedures.

Ketamine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Hypertension: elevated blood pressure during or after administration. - Tachycardia: increased heart rate. - Nausea: feeling of sickness. - Vomiting: expulsion of stomach contents. - Dissociation: sense of detachment from reality. - Hallucinations: visual or auditory disturbances.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort. - Severe hypertension: markedly high blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Neurotoxicity: potential neuronal injury with high or repeated doses. - Laryngospasm: involuntary vocal cord closure. - Allergic reaction: rash, itching, or anaphylaxis.

Ketamine requires careful assessment and monitoring to minimize risks.

- Assess cardiovascular status: monitor blood pressure and heart rate before and during administration. - Screen for psychiatric history: avoid in patients with schizophrenia or severe psychosis. - Use with caution in the elderly: adjust monitoring due to altered pharmacodynamics. - Avoid concurrent use with MAO inhibitors: increased risk of hypertensive events. - Store at ambient temperature: keep in original container, protect from light and moisture.

Ketamine can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Concurrent use with other NMDA antagonists: additive central nervous system depression. - Combination with potent CYP450 inhibitors (e.g., ketoconazole): may increase plasma concentrations. - Co‑administration with CNS depressants (e.g., opioids, benzodiazepines): heightened risk of respiratory depression.

Moderate Interactions (Monitor Closely): - Use with sympathomimetic agents (e.g., epinephrine): may exacerbate hypertension. - Interaction with MAO inhibitors: possible hypertensive crisis.